Your Article Summary
MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination
Avigen, 06/26/09
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, and Avigen, Inc. , a biopharmaceutical company, announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies' broad neurological clinical development programs based on ibudilast.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09

See Latest Articles